The cognate ligands to these molecules are highly expressed on other T cells (with CTLA-4 competing with B7 co-stimulation for CD28 binding) on APCs (with PD-L1 on DCs and macrophages), or on the tumor cells themselves (primarily PD-L1). The gene discussed is CD274; the disease is neoplasm.